No quarterly revenue total was found in BETTERLIFE PHARMA INC.'s SEC filings.
Betterlife Pharma Inc. (BETRF) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
$-3.38M
-736.4% vs year-ago quarter
Operating cash flow
$-705,895
-633.9% vs year-ago quarter
Free cash flow
—
EPS
$-0.04
-500.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
145.49M
+24.3% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BETRF (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1464165
- Former names
- Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2019 Oct 31, 2018 |
Q2 FY2019 Jul 31, 2018 |
Q4 FY2018 Jan 31, 2018 |
Q3 FY2018 Oct 31, 2017 |
Q2 FY2018 Jul 31, 2017 |
|---|---|---|---|---|---|
| Operating income | -$1.4M | -$1.2M | -$330,324 | -$184,658 | -$248,755 |
| Net income | -$3.4M | -$1.4M | -$326,544 | $530,726 | -$5,556 |
| Diluted EPS | -$0.04 | — | — | $0.01 | — |
| Operating cash flow | -$705,895 | -$2.9M | -$195,891 | -$96,189 | -$38,540 |
| Total assets | $7.1M | $7.6M | $383,817 | $535,159 | $36,038 |
| Total liabilities | — | $4.3M | $429,200 | $352,222 | — |
| Stockholders' equity | $3.4M | $3.3M | -$45,383 | $182,937 | -$1.3M |
| Cash and investments | $406,901 | $474,491 | $64,511 | $250,386 | $9,943 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 29, 2026 |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Sep 11, 2026 |
| 6-K | Current report (foreign issuer) | Aug 24, 2026 | Aug 24, 2026 |
| 6-K | Current report (foreign issuer) | Aug 5, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Apr 30, 2026 |
All 244 Betterlife Pharma Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.